Login / Signup

Potential Interactions of Remdesivir with Pulmonary Drugs: a Covid-19 Perspective.

Zainab GandhiZeeshan MansuriSnehal Bansod
Published in: SN comprehensive clinical medicine (2020)
In this letter, we discuss the potential interactions of remdesivir, the newly approved Covid-19 drug with pulmonary medications. These interactions have been summarized keeping the busy clinician in mind. While remdesivir has proven to be a safe medication generally, we here have enlisted the potential interactions of remdesivir that a clinician needs to be mindful of while prescribing the medication.
Keyphrases
  • coronavirus disease
  • sars cov
  • pulmonary hypertension
  • adverse drug
  • healthcare
  • primary care
  • human health
  • risk assessment
  • climate change